|
Volumn 18, Issue 7, 2012, Pages 979-981
|
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
PREDNISONE;
PROTEIN TYROSINE KINASE INHIBITOR;
CYTOTOXIN;
HLA ANTIGEN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ALLOTRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER PROGNOSIS;
CANCER SURVIVAL;
CONDITIONING;
CYTOTOXICITY;
EVENT FREE SURVIVAL;
EVIDENCE BASED PRACTICE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HLA MATCHING;
HUMAN;
LEUKEMIA REMISSION;
MEDICAL CARE;
MINIMAL RESIDUAL DISEASE;
NOTE;
WHOLE BODY RADIATION;
AUTOTRANSPLANTATION;
CHILD;
HISTOCOMPATIBILITY TEST;
IMMUNOLOGY;
METHODOLOGY;
PRACTICE GUIDELINE;
PRESCHOOL CHILD;
RECURRENT DISEASE;
REMISSION;
REVIEW;
CHILD;
CHILD, PRESCHOOL;
CYTOTOXINS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
RECURRENCE;
REMISSION INDUCTION;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 84877128533
PISSN: 10838791
EISSN: 15236536
Source Type: Journal
DOI: 10.1016/j.bbmt.2012.03.011 Document Type: Note |
Times cited : (25)
|
References (3)
|